PubMed=174098; DOI=10.1073/pnas.73.1.228
Epstein A.L., Henle W., Henle G., Hewetson J.F., Kaplan H.S.
Surface marker characteristics and Epstein-Barr virus studies of two established North American Burkitt's lymphoma cell lines.
Proc. Natl. Acad. Sci. U.S.A. 73:228-232(1976)

PubMed=205666; DOI=10.1093/jnci/60.5.991
Koliais S., Bjursell G., Adams A., Lindahl T.L., Klein G.
State of Epstein-Barr virus DNA in an American Burkitt's lymphoma line.
J. Natl. Cancer Inst. 60:991-994(1978)

PubMed=83902; DOI=10.1002/1097-0142(197901)43:1<1::AID-CNCR2820430102>3.0.CO;2-M
Kaplan H.S., Goodenow R.S., Gartner S., Bieber M.M.
Biology and virology of the human malignant lymphomas: 1st Milford D Schulz Lecture.
Cancer 43:1-24(1979)

PubMed=371794
Epstein A.L., Kaplan H.S.
Feeder layer and nutritional requirements for the establishment and cloning of human malignant lymphoma cell lines.
Cancer Res. 39:1748-1759(1979)

PubMed=6804087; DOI=10.1002/1097-0142(19820501)49:9<1817::AID-CNCR2820490914>3.0.CO;2-F
Grogan T.M., Warnke R.A., Kaplan H.S.
A comparative study of Burkitt's and non-Burkitt's 'undifferentiated' malignant lymphoma: immunologic, cytochemical, ultrastructural, cytologic, histopathologic, clinical and cell culture features.
Cancer 49:1817-1828(1982)

PubMed=3026973; DOI=10.1002/ijc.2910390215
Ehlin-Henriksson B., Manneborg-Sandlund A., Klein G.
Expression of B-cell-specific markers in different Burkitt lymphoma subgroups.
Int. J. Cancer 39:211-218(1987)

PubMed=24590883; DOI=10.1002/gcc.22161
Murga Penas E.-M., Schilling G., Behrmann P., Klokow M., Vettorazzi E., Bokemeyer C., Dierlamm J.
Comprehensive cytogenetic and molecular cytogenetic analysis of 44 Burkitt lymphoma cell lines: secondary chromosomal changes characterization, karyotypic evolution, and comparison with primary samples.
Genes Chromosomes Cancer 53:497-515(2014)